期刊文献+

3种不同促排卵方案在高龄不孕患者IVF/ICSI-ET中的临床应用分析 被引量:19

Clinical application of three different controlled ovarian hyperstimulation protocols in vitro fertilization/intracytoplasmic sperm injection and embryo transfer in elderly infertile patients
下载PDF
导出
摘要 目的探究高龄女性体外受精-胚胎移植(IVF/ICSI-ET)助孕过程中3种不同促排卵方案的临床结局。方法回顾性分析行助孕治疗且年龄≥35岁共447例患者的首次新鲜周期临床资料,按照促排卵方案不同分为:促性腺激素激动剂(GnRH-α)长方案组(192个周期),GnRH-α短方案组(162个周期),微刺激方案组(93个周期),比较3组病例一般临床资料及助孕结局。结果 (1)3组患者在年龄、不孕年限、基础促黄体生成素(LH)、基础雌激素(E2)上差异无统计学意义。但是,GnRH-α长方案组的基础窦卵数(b AFC)、促性腺激素(Gn)使用天数、获卵数、优质胚胎数明显高于其他两组,差异有统计学意义(P<0.05);(2)3组Gn使用总量、h CG日LH水平,组间差异有统计学意义(P<0.05),其中长方案组的Gn使用总量是最高的,微刺激方案组的h CG日LH水平高于其他两组。GnRH-α长方案组的临床妊娠率和活产率明显高于GnRH-α短方案组和微刺激方案组(P<0.05);(3)微刺激方案组的新鲜周期取消率最高。微刺激方案组与GnRH-α短方案组相比,临床妊娠率和活产率两组间差异无统计学意义。结论 GnRH-α长方案较适用于卵巢功能较好的高龄不孕患者,可取得较好的临床妊娠率及活产率。对于卵巢功能稍差的高龄患者,微刺激方案是一个安全、经济的促排卵方案,值得在合适的患者中推广应用。 Objective To explore the clinical outcome of three different controlled ovarian hyperstimulation protocols in vitro fertilization or intracytoplasmic sperm injection-embryo transfer(IVF/ICSI-ET) in elderly infertile patients.Methods A retrospective analysis was performed in a total of 447 patients aged ≥35 undergoing IVF/ICSI-ET treatment.They were divided into three groups according to the different stimulation protocols:GnRH-α long group(192 cycles),GnRH-α short group(162 cycles),micro simulation group(93 cycles).Finally,The clinical data of 3 groups and the results of assisted pregnancy were compared.Results(1) There were no statistically differences in the age,duration of infertility,the level of basic LH and E2.However,the basic antral follicle(b AFC),gonadotropin(Gn) time,the number of collected eggs,and high-quality embryos of the GnRH-α long group were significantly higher than those in the other two groups(P0.05).The total amount of Gn and the level of LH on h CG injection day were statistically differenct between the three groups(P0.05).(2) The total amount of Gn of the GnRH-α long group was the highest.The level of LH on h CG injection day of the micro simulation group was significantly higher than that in the other two groups.Clinical pregnancy rate and live birth rate of the GnRH-α long group were signicificantly higher than the GnRH-α short group and the micro stimulation group(P0.05).(3) Cycle cancelled rate of the micro simulation group was the highest.There was no significant differences of the clinical pregnancy rate and live birth rate between the GnRH-α short program group and the micro stimulation group.But the micro stimulation group had a slightly higher trend.Conclusion The GnRH-α long protocal is more suitable for those elderly patients with better ovarian function and can achieve better clinical pregnancy rate and live birth rate.For those elderly patients with slightly less ovarian function,the micro stimulation protocal is a safe and economical ovulation program that deserves to be used in the right patients.
作者 王靖 邢琼 王超 纪冬梅 徐千花 徐玉萍 贺小进 曹云霞 Wang Jing;Xing Qiong;Wang Chao(Reproductive Medicine Center,Dept of Obstetrics and Gynecology,The First Affiliated Hospital of Anhui Medical University,Anhui Province Key Laboratory of Reproductive Health and Genetics,Anhui Medical University,Anhui Provincial Engineering Technology Research Center for Biopreservation and Artificial Organs,Hefei 23002)
出处 《安徽医科大学学报》 CAS 北大核心 2018年第7期1080-1084,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81601345)
关键词 高龄 IVF GnRH-α长方案 GnRH-α短方案 微刺激 advanced age IVF GnRH-α long protocol GnRH-α short protocol micro simulation
  • 相关文献

参考文献6

二级参考文献54

  • 1徐千花,曹云霞,魏兆莲,丛林,章志国.不同促排卵方法在卵巢储备功能下降患者中的应用[J].生殖与避孕,2009,29(1):51-54. 被引量:28
  • 2Brzechffa PR, Daneshmand S, Buyalos RP. Sequential clomi-phene citrate and human menopausal gonadotrophin with intra- uterine insemination: the effect of patient age on clinical out- come. Human Reprod,1998,13(8) :2110-2114.
  • 3Van Hooff MH,Alberda AT, Huisman C-J, et al.Doubling the human menopausat gonadotrophin dose in the course of anin vitro fertilization treatment cycle in low responders:a random- ized study[J]. Hum Reprod,1993,8(3) :369-373.
  • 4Gleicher N, Weghofer A, Barad D. Too old for IVF:are we discrimin- ating against older women? [J]. J Assist Reprod Genet, 2007,24(12):639-644.
  • 5Ching-Chien,Chang,PhD,et al. Prospective controlled study to evaluate laboratory and clinical outcomes of oocyte vitrification obtained in in vitro fertilization patients aged 30 to 39 years [J]. Fertility and Sterility, 2013,99(7) : 1891 - 1897.
  • 6American Society for Reproductive Medicine. Aging and infertility in women[J]. Ferlil Steril, 2006, 86(5 Suppl 1):S248-S252.
  • 7Ilse A, Jvan Rooij, Laszlo FJM, M Bancsi, et al. Women older than 40 years of age and those with elevated folliele-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization[J]. Fertility and Sterility, 2003,79(3) : 482-488.
  • 8American Society for Reproductive Medicine. Age-related fertility decline :a committee opinion [J]. Fertil Steril,2008,90 (5 Suppl) : S154-S155.
  • 9Pellestor F, Andreo B, Anahory T, et al. The occurrence of aneuploidy in human:lessons from the cytogenetic studies of human oocytes [J]. Eur J Med Genet, 2006,49(2) : 103-116.
  • 10Jinsong Xiao,Shuang Chang, Shuangyun Chen. The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization:a systematic review and meta-analysis[J]. Fertility and Sterility, 2013,100(6): 1594-1601.

共引文献51

同被引文献151

引证文献19

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部